Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A06997 | 32666779 | Pol Arch Intern Med | Nonalcoholic fatty liver disease and the risk of metabolic comorbidities: how to manage in clinical practice. | 2020 | Details |
A06998 | 32666675 | Liver Int | Hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy: The emerging role of non-viral risk factors. | 2020 | Details |
A06999 | 32666604 | FASEB J | Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD. | 2020 | Details |
A07000 | 32665525 | Gastroenterol Nurs | Ulcerative Colitis as an Independent Risk Factor for Hepatic Steatosis. | 2021 | Details |
A07001 | 32664383 | Antioxidants (Basel) | The Interplay between Oxidative Stress and miRNAs in Obesity-Associated Hepatic and Vascular Complications. | 2020 | Details |
A07002 | 32664153 | Medicine (Baltimore) | Correlation between the small dense LDL level and nonalcoholic fatty liver disease: Possibility of a new biomarker. | 2020 | Details |
A07003 | 32663815 | J Breath Res | High intestinal hydrogen production in runners after intake of fructose solution. | 2020 | Details |
A07004 | 32663612 | Ann Hepatol | Mediterranean-like mix of fatty acids induces cellular protection on lipid-overloaded hepatocytes from western diet fed mice. | 2020 | Details |
A07005 | 32663610 | Biochim Biophys Acta Mol Cell Biol Lipids | Glucosamine regulates hepatic lipid accumulation by sensing glucose levels or feeding states of normal and excess. | 2020 | Details |
A07006 | 32663195 | J Clin Invest | Hemolysis transforms liver macrophages into antiinflammatory erythrophagocytes. | 2020 | Details |
A07007 | 32660189 | Zhonghua Gan Zang Bing Za Zhi | [Pancreatoduodenectomy and non-alcoholic fatty liver disease]. | 2020 | Details |
A07008 | 32660172 | Zhonghua Gan Zang Bing Za Zhi | [Carcinoembryonic type specific markers and liver cancer immunotherapy]. | 2020 | Details |
A07009 | 32660170 | Zhonghua Gan Zang Bing Za Zhi | [Strategies and challenges of immunotherapy for hepatocellular carcinoma]. | 2020 | Details |
A07010 | 32660150 | Int J Mol Sci | Intracellular Toxic Advanced Glycation End-Products Promote the Production of Reactive Oxygen Species in HepG2 Cells. | 2020 | Details |
A07011 | 32660130 | Metabolites | Transcriptional Regulation in Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
A07012 | 32659827 | Z Gastroenterol | [Choosing wisely - perspectives: what are the key questions?] | 2020 | Details |
A07013 | 32657776 | J Clin Invest | AGER1 downregulation associates with fibrosis in nonalcoholic steatohepatitis and type 2 diabetes. | 2020 | Details |
A07014 | 32657670 | J Am Coll Nutr | Hepatoprotective Effect of Antrodia cinnamomea Mycelium in Patients with Nonalcoholic Steatohepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial. | 2020 | Details |
A07015 | 32657010 | Obesity (Silver Spring) | Hepatocyte Notch Signaling Deregulation Related to Lipid Metabolism in Women with Obesity and Nonalcoholic Fatty Liver. | 2020 | Details |
A07016 | 32655764 | Oxid Med Cell Longev | Gentiopicroside Ameliorates Oxidative Stress and Lipid Accumulation through Nuclear Factor Erythroid 2-Related Factor 2 Activation. | 2020 | Details |
A07017 | 32655370 | Front Cell Neurosci | Dyslipidemic Diet Induces Mobilization of Peripheral Neutrophils and Monocytes That Exacerbate Hemorrhagic Brain Injury and Neuroinflammation. | 2020 | Details |
A07018 | 32655232 | J Clin Exp Hepatol | Diabetes and Hepatocellular Carcinoma: Incidence Trends and Impact of Liver Disease Etiology. | 2019 | Details |
A07019 | 32655229 | J Clin Exp Hepatol | Vascular Endothelial Growth Factor Promotes Proliferation of Epithelial Cell Adhesion Molecule-Positive Cells in Nonalcoholic Steatohepatitis. | 2019 | Details |
A07020 | 32654989 | Pancreatology | Three-dimensional remnant pancreatic volume ratio indicates postoperative pancreatic exocrine insufficiency in pancreatic cancer patients after distal pancreatectomy. | 2020 | Details |
A07021 | 32654868 | J Formos Med Assoc | Non-alcoholic fatty liver disease: A review with clinical and pathological correlation. | 2020 | Details |
A07022 | 32654591 | Biosci Biotechnol Biochem | Effect and mechanism of ginsenoside Rg1-regulating hepatic steatosis in HepG2 cells induced by free fatty acid. | 2020 | Details |
A07023 | 32654534 | Arch Physiol Biochem | Fish oil and chicoric acid combination protects better against palmitate-induced lipid accumulation via regulating AMPK-mediated SREBP-1/FAS and PPARα/UCP2 pathways. | 2020 | Details |
A07024 | 32654522 | Arch Physiol Biochem | The common variant of rs6214 in insulin like growth factor 1 (IGF1) gene: a potential protective factor for non-alcoholic fatty liver disease. | 2020 | Details |
A07025 | 32654390 | Liver Int | The association of non-alcoholic fatty liver disease and cardiac structure and function-Framingham Heart Study. | 2020 | Details |
A07026 | 32654086 | Dig Dis Sci | Nonalcoholic Fatty Liver Disease Risk Factors Affect Liver-Related Outcomes After Direct-Acting Antiviral Treatment for Hepatitis C. | 2020 | Details |
A07027 | 32652824 | Liver Int | NAFLD is related to Post-prandial Triglyceride-enrichment of HDL Particles in Association with Endothelial and HDL Dysfunction. | 2020 | Details |
A07028 | 32652799 | Liver Int | High-protein diet more effectively reduces hepatic fat than low-protein diet despite lower autophagy and FGF21 levels. | 2020 | Details |
A07029 | 32652744 | Liver Int | MR elastography-based liver fibrosis correlates with liver events in nonalcoholic fatty liver patients: A multicenter study. | 2020 | Details |
A07030 | 32652145 | Gastroenterology | Intestinal Virome Signature Associated With Severity of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
A07031 | 32651233 | J Biol Chem | From overnutrition to liver injury: AMP-activated protein kinase in nonalcoholic fatty liver diseases. | 2020 | Details |
A07032 | 32650722 | BMC Gastroenterol | Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study. | 2020 | Details |
A07033 | 32650421 | Cells | Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
A07034 | 32650222 | Nutr Res | Distinct utilization of biotin in and between adipose and brain during aging is associated with a lipogenic shift in Wistar rat brain. | 2020 | Details |
A07035 | 32650090 | Comput Methods Programs Biomed | Computer-aided classification of hepatocellular ballooning in liver biopsies from patients with NASH using persistent homology. | 2020 | Details |
A07036 | 32649794 | Acta Paediatr | Prevalence of elevated liver enzymes and comorbidities in children and adolescents with overweight and obesity. | 2020 | Details |
A07037 | 32649507 | Chin Med J (Engl) | Intestinal epithelial chemokine (C-C motif) ligand 7 overexpression protects against high fat diet-induced obesity and hepatic steatosis in mice. | 2020 | Details |
A07038 | 32648699 | Adv Biosyst | A Human Liver-on-a-Chip Platform for Modeling Nonalcoholic Fatty Liver Disease. | 2019 | Details |
A07039 | 32648647 | Obes Rev | Scientific evidence underlying contraindications to the ketogenic diet: An update. | 2020 | Details |
A07040 | 32647367 | Eur J Clin Nutr | The efficacy of flaxseed and hesperidin on non-alcoholic fatty liver disease: an open-labeled randomized controlled trial. | 2020 | Details |
A07041 | 32646847 | Clin Res Hepatol Gastroenterol | Concurrence of HBV infection and non-alcoholic fatty liver disease is associated with higher prevalence of chronic kidney disease. | 2020 | Details |
A07044 | 32645536 | Cytokine | Combination of asprosin and adiponectin as a novel marker for diagnosing non-alcoholic fatty liver disease. | 2020 | Details |
A07046 | 32645206 | Cochrane Database Syst Rev | Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis. | 2020 | Details |
A07047 | 32643289 | Physiol Rep | Modifying nutritional substrates induces macrovesicular lipid droplet accumulation and metabolic alterations in a cellular model of hepatic steatosis. | 2020 | Details |
A07048 | 32643194 | Prenat Diagn | Perinatal exposure to maternal obesity: Lasting cardiometabolic impact on offspring. | 2020 | Details |
A07049 | 32642003 | Theranostics | Current understanding of the role of Adipose-derived Extracellular Vesicles in Metabolic Homeostasis and Diseases: Communication from the distance between cells/tissues. | 2020 | Details |
A07050 | 32641615 | J Oleo Sci | Basil Essential Oil and Its Nanoemulsion Mitigate Non Alcoholic Steatohepatitis in Rat Model with Special Reference to Gut Microbiota. | 2020 | Details |
A07051 | 32640454 | Pharmacology | Molecular Study on the Potential Protective Effects of Bee Venom against Fructose-Induced Nonalcoholic Steatohepatitis in Rats. | 2020 | Details |
A07052 | 32640331 | Food Chem Toxicol | Analysis of the intricate effects of polyunsaturated fatty acids and polyphenols on inflammatory pathways in health and disease. | 2020 | Details |
A07053 | 32640105 | J Intern Med | A systems biology approach to understand gut microbiota and host metabolism in morbid obesity: design of the BARIA Longitudinal Cohort Study. | 2020 | Details |
A07054 | 32639223 | Int J Vitam Nutr Res | Vitamin D levels are not associated with non-alcoholic fatty liver disease severity in a Brazilian population. | 2020 | Details |
A07055 | 32638913 | Rev Col Bras Cir | Comparison of the severity of non-alcoholic fatty liver disease in diabetic and non-diabetic obese patients. | 2020 | Details |
A07056 | 32638543 | Pediatr Obes | Significance of autoantibody seropositivity in children with obesity and non-alcoholic fatty liver disease. | 2020 | Details |
A07057 | 32638541 | J Cachexia Sarcopenia Muscle | Association between muscle strength and advanced fibrosis in non-alcoholic fatty liver disease: a Korean nationwide survey. | 2020 | Details |
A07058 | 32638496 | Liver Int | Non-invasive risk scores do not reliably identify future cirrhosis or hepatocellular carcinoma in Type 2 diabetes: The Edinburgh type 2 diabetes study. | 2020 | Details |
A07059 | 32638492 | Aging Cell | Liver osteopontin is required to prevent the progression of age-related nonalcoholic fatty liver disease. | 2020 | Details |
A07060 | 32638417 | Aliment Pharmacol Ther | Review article: the impact of liver-directed therapies on the atherogenic risk profile in non-alcoholic steatohepatitis. | 2020 | Details |
A07061 | 32637906 | JHEP Rep | The liver matrisome - looking beyond collagens. | 2020 | Details |
A07062 | 32636281 | BMJ Open | Protocol for a phase IV, open-label feasibility study investigating non-invasive markers of hepatic fibrosis in people living with HIV-1 and non-alcoholic fatty liver disease randomised to receiving optimised background therapy (OBT) plus maraviroc or OBT alone. | 2020 | Details |
A07063 | 32636124 | Nutr Metab Cardiovasc Dis | Lower levels of plasma NT-proBNP are associated with higher prevalence of NASH in patients with biopsy-proven NAFLD. | 2020 | Details |
A07064 | 32636123 | Nutr Metab Cardiovasc Dis | PNPLA3 gene polymorphism is associated with liver steatosis in children with Down syndrome. | 2020 | Details |
A07065 | 32634767 | J Trace Elem Med Biol | The sex-specific effects of blood lead, mercury, and cadmium levels on hepatic steatosis and fibrosis: Korean nationwide cross-sectional study. | 2020 | Details |
A07066 | 32634622 | Clin Gastroenterol Hepatol | Real-World Burden of Nonalcoholic Steatohepatitis. | 2020 | Details |
A07067 | 32634278 | J Intern Med | Liver mitochondrial DNA damage and genetic variability of Cytochrome b - a key component of the respirasome - drive the severity of fatty liver disease. | 2020 | Details |
A07068 | 32633900 | Liver Int | Training of hepatology providers improves the screening and resultant interventions for alcohol use disorder. | 2020 | Details |
A07069 | 32633873 | J Intern Med | Nonalcoholic fatty liver disease is associated with a decreased myocardial mechano-energetic efficiency. | 2020 | Details |
A07070 | 32632389 | Transl Gastroenterol Hepatol | Acute-on-chronic liver failure in liver transplant candidates with non-alcoholic steatohepatitis. | 2020 | Details |
A07071 | 32632387 | Transl Gastroenterol Hepatol | Pathogenesis of non-alcoholic fatty liver disease and implications on cardiovascular outcomes in liver transplantation. | 2020 | Details |
A07072 | 32631678 | Rev Neurol (Paris) | Metabolic alterations in spinal and bulbar muscular atrophy. | 2020 | Details |
A07073 | 32631515 | Bioorg Med Chem Lett | Development of a new class of liver receptor homolog-1 (LRH-1) agonists by photoredox conjugate addition. | 2020 | Details |
A07074 | 32631250 | BMC Gastroenterol | Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis. | 2020 | Details |
A07075 | 32630984 | Korean J Intern Med | Impact of nonalcoholic fatty liver disease on the risk of metachronous colorectal neoplasia after polypectomy. | 2020 | Details |
A07076 | 32630732 | Antioxidants (Basel) | Serum Malondialdehyde is Associated with Non-Alcoholic Fatty Liver and Related Liver Damage Differentially in Men and Women. | 2020 | Details |
A07077 | 32630610 | Biomedicines | Risk Factors Contributing to the Occurrence and Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus Patients Treated with Direct-Acting Antivirals. | 2020 | Details |
A07078 | 32630596 | Int J Mol Sci | SGL 121 Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism Through AMPK Signaling Pathway. | 2020 | Details |
A07079 | 32630407 | Diagnostics (Basel) | Accuracy of a Semi-Quantitative Ultrasound Method to Determine Liver Fat Infiltration in Early Adulthood. | 2020 | Details |
A07080 | 32629641 | Medicine (Baltimore) | Efficacy and safety of incretin-based therapies in patients with nonalcoholic fatty liver disease: A protocol for a systematic review and meta-analysis. | 2020 | Details |
A07082 | 32629394 | EBioMedicine | MBOAT7 down-regulation by genetic and environmental factors predisposes to MAFLD. | 2020 | Details |
A07083 | 32629127 | Clin Gastroenterol Hepatol | Enhanced Liver Fibrosis Score Can Be Used to Predict Liver-Related Events in Patients With Nonalcoholic Steatohepatitis and Compensated Cirrhosis. | 2020 | Details |
A07084 | 32629123 | Clin Gastroenterol Hepatol | Lean Americans With Nonalcoholic Fatty Liver Disease Have Lower Rates of Cirrhosis and Comorbid Diseases. | 2020 | Details |
A07085 | 32628898 | United European Gastroenterol J | Metabolic endoscopy: Today's science-tomorrow's treatment. | 2020 | Details |
A07086 | 32628351 | J Diabetes Investig | Loss of metabolic flexibility as a result of overexpression of pyruvate dehydrogenase kinases in muscle, liver and the immune system: Therapeutic targets in metabolic diseases. | 2020 | Details |
A07087 | 32627871 | J Gastroenterol Hepatol | Patient-reported outcomes in patients with non-alcoholic fatty liver disease: A narrative review of Chronic Liver Disease Questionnaire-non-alcoholic fatty liver disease/non-alcoholic steatohepatitis. | 2020 | Details |
A07088 | 32627436 | J Korean Med Sci | Elevated Alanine Aminotransferase in Early Pregnancy and Subsequent Development of Gestational Diabetes and Preeclampsia. | 2020 | Details |
A07089 | 32626837 | Hepatol Commun | Activation of Adenosine Monophosphate-Activated Protein Kinase Reduces the Onset of Diet-Induced Hepatocellular Carcinoma in Mice. | 2020 | Details |
A07090 | 32626832 | Hepatol Commun | Health Care Use and Costs Among Patients With Nonalcoholic Steatohepatitis With Advanced Fibrosis Using the Fibrosis-4 Score. | 2020 | Details |
A07091 | 32626829 | Hepatol Commun | Prevalence and Profile of Nonalcoholic Fatty Liver Disease in Lean Adults: Systematic Review and Meta-Analysis. | 2020 | Details |
A07092 | 32626782 | J Diabetes Res | Thrombospondin-1: A Key Protein That Induces Fibrosis in Diabetic Complications. | 2020 | Details |
A07093 | 32626560 | Middle East J Dig Dis | Assessment of Genetic Aspects of Non-alcoholic Fatty Liver and Premature Cardiovascular Events. | 2020 | Details |
A07094 | 32625166 | Front Endocrinol (Lausanne) | Serum Ferritin Correlates With Liver Fat in Male Adolescents With Obesity. | 2020 | Details |
A07095 | 32623698 | Cell Biol Toxicol | Gestational bisphenol A exposure induces fatty liver development in male offspring mice through the inhibition of HNF1b and upregulation of PPARγ. | 2020 | Details |
A07096 | 32623632 | Hepatol Int | Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study). | 2020 | Details |
A07097 | 32623384 | Cancer Biomark | Identification of genes in hepatocellular carcinoma induced by non-alcoholic fatty liver disease. | 2020 | Details |
A07098 | 32623006 | Clin Gastroenterol Hepatol | Prevalence of Liver Steatosis and Fibrosis Detected by Transient Elastography in Adolescents in the 2017-2018 National Health and Nutrition Examination Survey. | 2020 | Details |
A07099 | 32622843 | Metabolism | Defects in High Density Lipoprotein metabolism and hepatic steatosis in mice with liver-specific ablation of Hepatocyte Nuclear Factor 4A. | 2020 | Details |
A07100 | 32622362 | J Neuroinflammation | Lipocalin 2 induces neuroinflammation and blood-brain barrier dysfunction through liver-brain axis in murine model of nonalcoholic steatohepatitis. | 2020 | Details |